11 assets in Hereditary Persistence Of Fetal Hemoglobin

Therapeutic assets addressing Hereditary Persistence Of Fetal Hemoglobin, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Busulfanum Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Cyclophosphamide Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Hydroxyurea Hereditary Persistence Of Fetal Hemoglobin	National Institute of Blood and Marrow Transplant (NIBMT), Pakistan	P2	CCC (53)
Melphalan Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Rituximab Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Thalidomide Hereditary Persistence Of Fetal Hemoglobin	National Institute of Blood and Marrow Transplant (NIBMT), Pakistan	P2	CCC (53)
Cord Blood Red Blood Cells Hereditary Persistence Of Fetal Hemoglobin	Hospital Clinic of Barcelona	N/A	D (30)
Red Blood Cells Hereditary Persistence Of Fetal Hemoglobin	Hospital Clinic of Barcelona	N/A	D (30)